A Phase I, Open-label, Dose-escalation, Safety Study of the Combination of EPO906 and Radiation Therapy for the Treatment of Patients With Cancer.

Trial Profile

A Phase I, Open-label, Dose-escalation, Safety Study of the Combination of EPO906 and Radiation Therapy for the Treatment of Patients With Cancer.

Completed
Phase of Trial: Phase I

Latest Information Update: 11 Mar 2011

At a glance

  • Drugs Patupilone (Primary)
  • Indications Head and neck cancer; Solid tumours
  • Focus Adverse reactions
  • Most Recent Events

    • 19 Aug 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 19 Aug 2010 Actual end date (Jul 2009) added as reported by ClinicalTrials.gov.
    • 04 Jun 2009 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top